13 Low back pain becomes chronic in up to 23% of patients and recurs within one year in up to 80%
Draw air into the syringe (the same number of milliliters as the vitamin you plan to inject)
Not for human consumption, therapeutic, or diagnostic purposes
Mechanisms of action: two distinct cascades BPC-157: NO pathway modulation and growth factor expression Preclinical studies have suggested that BPC-157 acts primarily through three axes: NO (nitric oxide) pathway : BPC-157 modulates endothelial NO signaling, favoring local vasodilation and perfusion of injured tissues VEGF-R2 expression and angiogenesis : animal models have shown increased formation of new capillaries at the injury site Interactions with dopaminergic, serotonergic and GABAergic pathways : BPC-157 exhibits a pleiotropic profile influencing neurological and digestive healing Documented strengths (animal models): healing of tendons, ligaments, gastrointestinal mucosa, bone, teeth, vessels, cornea
This involves administering the peptide as close as safely possible to the actual injury